These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24995950)

  • 1. Target-specific delivery of siRNA by stabilized calcium phosphate nanoparticles using dopa-hyaluronic acid conjugate.
    Lee MS; Lee JE; Byun E; Kim NW; Lee K; Lee H; Sim SJ; Lee DS; Jeong JH
    J Control Release; 2014 Oct; 192():122-30. PubMed ID: 24995950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilized calcium phosphate nano-aggregates using a dopa-chitosan conjugate for gene delivery.
    Lee K; Oh MH; Lee MS; Nam YS; Park TG; Jeong JH
    Int J Pharm; 2013 Mar; 445(1-2):196-202. PubMed ID: 23328681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic delivery of siRNA by hyaluronan-functionalized calcium phosphate nanoparticles for tumor-targeted therapy.
    Qiu C; Wei W; Sun J; Zhang HT; Ding JS; Wang JC; Zhang Q
    Nanoscale; 2016 Jul; 8(26):13033-44. PubMed ID: 27314204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic cancer therapy by systemic administration of VEGF siRNA contained in calcium phosphate/charge-conversional polymer hybrid nanoparticles.
    Pittella F; Miyata K; Maeda Y; Suma T; Watanabe S; Chen Q; Christie RJ; Osada K; Nishiyama N; Kataoka K
    J Control Release; 2012 Aug; 161(3):868-74. PubMed ID: 22580114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F127/Calcium phosphate hybrid nanoparticles: a promising vector for improving siRNA delivery and gene silencing.
    Qin L; Sun Y; Liu P; Wang Q; Han B; Duan Y
    J Biomater Sci Polym Ed; 2013; 24(15):1757-66. PubMed ID: 23746331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective systemic siRNA delivery using dual-layer protected long-circulating nanohydrogel containing an inorganic core.
    Yin Y; Lee MS; Lee JE; Lim SY; Kim ES; Jeong J; Kim D; Kim J; Lee DS; Jeong JH
    Biomater Sci; 2019 Aug; 7(8):3297-3306. PubMed ID: 31187795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Codelivery of GRP78 siRNA and docetaxel via RGD-PEG-DSPE/DOPA/CaP nanoparticles for the treatment of castration-resistant prostate cancer.
    Zhang X; He Z; Xiang L; Li L; Zhang H; Lin F; Cao H
    Drug Des Devel Ther; 2019; 13():1357-1372. PubMed ID: 31118572
    [No Abstract]   [Full Text] [Related]  

  • 9. Bioreducible Cross-Linked Hyaluronic Acid/Calcium Phosphate Hybrid Nanoparticles for Specific Delivery of siRNA in Melanoma Tumor Therapy.
    Zhou Z; Li H; Wang K; Guo Q; Li C; Jiang H; Hu Y; Oupicky D; Sun M
    ACS Appl Mater Interfaces; 2017 May; 9(17):14576-14589. PubMed ID: 28393529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate.
    Park K; Lee MY; Kim KS; Hahn SK
    Biomaterials; 2010 Jul; 31(19):5258-65. PubMed ID: 20378167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes.
    Choi KM; Jang M; Kim JH; Ahn HJ
    Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
    Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
    Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic siRNA delivery to a spontaneous pancreatic tumor model in transgenic mice by PEGylated calcium phosphate hybrid micelles.
    Pittella F; Cabral H; Maeda Y; Mi P; Watanabe S; Takemoto H; Kim HJ; Nishiyama N; Miyata K; Kataoka K
    J Control Release; 2014 Mar; 178():18-24. PubMed ID: 24440662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
    Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
    Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts.
    Yoshizawa T; Hattori Y; Hakoshima M; Koga K; Maitani Y
    Eur J Pharm Biopharm; 2008 Nov; 70(3):718-25. PubMed ID: 18647651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium carbonate nanoparticle delivering vascular endothelial growth factor-C siRNA effectively inhibits lymphangiogenesis and growth of gastric cancer in vivo.
    He XW; Liu T; Chen YX; Cheng DJ; Li XR; Xiao Y; Feng YL
    Cancer Gene Ther; 2008 Mar; 15(3):193-202. PubMed ID: 18202713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles.
    Li Y; Zhang J; Wang B; Shen Y; Ouahab A
    Drug Dev Ind Pharm; 2016; 42(5):737-46. PubMed ID: 26472259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatible and colloidally stabilized mPEG-PE/calcium phosphate hybrid nanoparticles loaded with siRNAs targeting tumors.
    Gao P; Zhang X; Wang H; Zhang Q; Li H; Li Y; Duan Y
    Oncotarget; 2016 Jan; 7(3):2855-66. PubMed ID: 26625203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.